Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis Brelated hepatocellular carcinoma following octreotide longacting release treatment

Author:      

Publisher: Spandidos Publications

ISSN: 1792-1074

Source: Oncology Letters, Vol.6, Iss.3, 2013-01, pp. : 821-828

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content